NYSE:EHAB

Enhabit (EHAB) Stock Price, News & Analysis

$10.27
+0.01 (+0.10%)
(As of 04:00 PM ET)
Today's Range
$10.14
$10.34
50-Day Range
$7.81
$11.65
52-Week Range
$7.12
$14.59
Volume
278,159 shs
Average Volume
573,803 shs
Market Capitalization
$515.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.08

Enhabit MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.86 Rating Score
Upside/​Downside
17.7% Upside
$12.08 Price Target
Short Interest
Healthy
8.02% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
25.00%
From $0.24 to $0.30 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.41 out of 5 stars

Medical Sector

667th out of 910 stocks

Home Health Care Services Industry

7th out of 8 stocks

EHAB stock logo

About Enhabit Stock (NYSE:EHAB)

Enhabit, Inc. is a leading healthcare provider that offers Medicare-certified skilled home health and hospice services in the United States. The company operates in two segments: Home Health and Hospice, providing services to adult patients needing care, including skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. Enhabit's hospice services include in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and emotional and spiritual support.

Enhabit operates home health agencies in approximately 34 states, with a concentration in the southern half of the United States. As of March 31, 2022, Enhabit operates in 252 home health agencies and 99 hospice agencies across 34 states. Enhabit provides practices to treat chronic diseases and conditions, including diabetes, arthritis, hypertension,  Alzheimer's disease, spinal stenosis, low vision,  Parkinson's disease, complex wound care, osteoporosis, and chronic pain, along with disease-specific plans for patients with diabetes, post-orthopedic surgery or injury, congestive heart failure,  and respiratory diseases.

Enhabit started as HealthSouth, founded in 1984 by Beam Scrushy and Richard Scrushy. In the early 2000s, the company restructured and rebranded into Encompass Health after being caught up in an accounting scandal. In Q2 of 2022, Enhabit, the healthcare and hospice division, became an independent public company, having completed its spinoff from Encompass Health Corporation. 

Barb Jacobsmeyer was named President and CEO of Enhabit Home Health & Hospice in June 2021. Jacobsmeyer came to Enhabit from Encompass Health, where she served as the company's executive vice president of operations. 

In Q3 of 2022, Enhabit, Inc. announced the acquisition of Caring Hearts Hospice, a locally-owned hospice agency in Texas. The acquisition adds four hospice locations in Texas to Enhabit's existing presence in the state. Ehnabit continues to expand, setting aside approximately one hundred million dollars to fund future mergers and acquisitions. 

Enhabit, Inc. is committed to providing high-quality care and service to patients and their families, and its success is a testament to its dedicated team of healthcare professionals. Enhabit is well-positioned to meet the growing demand for healthcare services in the United States as a leading home health and hospice service provider. With its focus on patient care and commitment to excellence, Enhabit is poised to continue to grow and succeed in the years ahead.

Enhabit's commitment to quality care has not gone unnoticed, as they have received numerous awards and recognitions for their services. In 2021, they were named a HomeCare Elite Top Agency for the 15th year. This recognition is given to the top-performing home health agencies in the United States. They have also received a 5-star rating from the Centers for Medicare & Medicaid Services (CMS) for their home health services, indicating their high quality and patient satisfaction.

Enhabit's success can be attributed to its skilled and compassionate staff and dedication to providing comprehensive and individualized patient care. Enhabit also recognizes the importance of emotional and spiritual support for their patients and their families, particularly in hospice care. Their hospice services include pain and symptom management, spiritual counseling, palliative and dietary counseling, social worker visits, and bereavement counseling services to meet terminally ill patients and their families' individual physical, spiritual, emotional, and psychosocial needs.

EHAB Stock Price History

EHAB Stock News Headlines

A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
A new way to collect income from stocks
Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…
Breaking Down Enhabit: 3 Analysts Share Their Views
Recap: Enhabit Q4 Earnings
See More Headlines
Receive EHAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enhabit and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/06/2024
Today
4/23/2024
Next Earnings (Confirmed)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Home health care services
Sub-Industry
N/A
Fax
N/A
Employees
10,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.08
High Stock Price Target
$15.00
Low Stock Price Target
$9.50
Potential Upside/Downside
+17.8%
Consensus Rating
Reduce
Rating Score (0-4)
1.86
Research Coverage
7 Analysts

Profitability

Net Income
$-80,500,000.00
Pretax Margin
-8.64%

Debt

Sales & Book Value

Annual Sales
$1.05 billion
Cash Flow
$2.60 per share
Book Value
$13.90 per share

Miscellaneous

Free Float
49,203,000
Market Cap
$514.64 million
Optionable
Optionable
Beta
1.96
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Ms. Barbara Ann Jacobsmeyer B.S. (Age 57)
    M.A., P.T., President, CEO & Director
    Comp: $1.26M
  • Ms. Crissy Buchanan Carlisle (Age 51)
    Executive VP & CFO
    Comp: $611.66k
  • Ms. Julie Diane Jolley B.S.N. (Age 51)
    R.N., Executive Vice President of Operations
    Comp: $642.65k
  • Ms. Tanya R. Marion (Age 49)
    Chief Human Resources Officer
    Comp: $445.86k
  • Ms. Jeanne Kalvaitis B.S.N. (Age 66)
    R.N., Executive Vice President of Hospice Operations
    Comp: $288.38k
  • Mr. Dylan C. Black (Age 54)
    General Counsel & Secretary
  • Mr. Ronald L. Langham Jr. (Age 46)
    M.B.A., P.T., Executive Vice President of Clinical Excellence & Strategy

EHAB Stock Analysis - Frequently Asked Questions

Should I buy or sell Enhabit stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Enhabit in the last year. There are currently 2 sell ratings, 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "reduce" EHAB shares.
View EHAB analyst ratings
or view top-rated stocks.

What is Enhabit's stock price target for 2024?

7 equities research analysts have issued twelve-month price objectives for Enhabit's stock. Their EHAB share price targets range from $9.50 to $15.00. On average, they predict the company's stock price to reach $12.08 in the next year. This suggests a possible upside of 17.7% from the stock's current price.
View analysts price targets for EHAB
or view top-rated stocks among Wall Street analysts.

How have EHAB shares performed in 2024?

Enhabit's stock was trading at $10.35 at the start of the year. Since then, EHAB stock has decreased by 0.8% and is now trading at $10.27.
View the best growth stocks for 2024 here
.

Are investors shorting Enhabit?

Enhabit saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 3,530,000 shares, a decline of 16.5% from the March 15th total of 4,230,000 shares. Based on an average daily trading volume, of 605,200 shares, the days-to-cover ratio is presently 5.8 days. Approximately 8.0% of the shares of the company are sold short.
View Enhabit's Short Interest
.

When is Enhabit's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our EHAB earnings forecast
.

How can I listen to Enhabit's earnings call?

Enhabit will be holding an earnings conference call on Thursday, May 9th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Enhabit's earnings last quarter?

Enhabit, Inc. (NYSE:EHAB) issued its earnings results on Wednesday, March, 6th. The company reported $0.03 earnings per share for the quarter, beating analysts' consensus estimates of $0.02 by $0.01. The firm had revenue of $260.60 million for the quarter, compared to analysts' expectations of $260.30 million. Enhabit had a negative net margin of 7.69% and a positive trailing twelve-month return on equity of 1.55%. During the same quarter in the prior year, the company earned $0.32 earnings per share.

What ETF holds Enhabit's stock?

Invesco S&P Spin-Off ETF holds 23,287 shares of EHAB stock, representing 0.43% of its portfolio.

What guidance has Enhabit issued on next quarter's earnings?

Enhabit issued an update on its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided EPS guidance of 0.120-0.430 for the period, compared to the consensus estimate of 0.220. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Who are Enhabit's major shareholders?

Enhabit's stock is owned by a variety of retail and institutional investors. Top institutional investors include Shikiar Asset Management Inc. (0.04%) and Allspring Global Investments Holdings LLC (0.01%). Insiders that own company stock include Barbara Ann Jacobsmeyer, Charles M Elson, Erin Hoeflinger, Gregory S Rush, Jeffrey Bolton, John E D D S Maupin Jr, L Edward Shaw Jr, Leo I Higdon Jr, Ronald Leroy Langham Jr and Tanya Renee Marion.
View institutional ownership trends
.

How do I buy shares of Enhabit?

Shares of EHAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:EHAB) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners